Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
2026.10.27
Wolfe Research Downgrades M&T Bank to Underperform
Benzinga
2026.10.27
Pfizer Announces That Topline Results In The Phase 3 MagnetisMM-32 Trial Of ELREXFIO Demonstrated Clinically Meaningful And Statistically Significant Benefit For Patients Whose Disease Progressed After Anti-CD38 Therapy And Lenalidomide, With Median PFS...
Benzinga
2026.10.27
Oppenheimer Initiates Coverage On MSC Income Fund with Outperform Rating, Announces Price Target of $15
Benzinga
2026.10.27
Aclaris Therapeutics Prices $50M Offering Of 7,785,714 Shares And Warrants To Purchase 6.5M Shares At $3.50/Unit
Benzinga
2026.10.27
Roth Capital Initiates Coverage On Dianthus Therapeutics with Buy Rating, Announces Price Target of $113
Benzinga
2026.10.27
Community Financial Q3 Adj. EPS $1.27 Beats $1.19 Estimate, Sales $227.291M Beat $224.672M Estimate
Benzinga
2026.10.27
Truist Securities Initiates Coverage On Northwest Natural Hldg with Hold Rating, Announces Price Target of $54
Benzinga
2026.10.27
Wolfe Research Downgrades Huntington Bancshares to Peer Perform
Benzinga
2026.10.27
Truist Securities Initiates Coverage On Evergy with Buy Rating, Announces Price Target of $97
Benzinga
2026.10.27
NVIDIA Commits $3 Billion to Meta, Expands Muse Partnership
Benzinga
2026.10.27
'Iran Says It Will Take Action Against Sinokor Ships in Hormuz' - Bloomberg
Benzinga
2026.10.27
HC Wainwright & Co. Reiterates Buy on Oruka Therapeutics, Maintains $120 Price Target
Benzinga
2026.10.27
BCE’s Subsidiary Bell Canada To Sell 49.9% Stake In Newly Formed Wireless Tower Infrastructure Company To La Caisse For C$2.45 Billion
Benzinga
2026.10.27
Atrium Therapeutics Doses First Patient In Its Phase 1/2 Corventis Clinical Trial Evaluating ATR 1072 For Potential Treatment Of PRKAG2 Syndrome; Expects Initial Proof-Of-Concept Data In H2 2027
Benzinga
2026.10.27
Needham Reiterates Buy on Monday.Com, Maintains $125 Price Target
Benzinga
2026.10.27
Innio Raises FY2026 Sales Guidance from $3.800B-$3.900B to $3.900B-$4.000B vs $3.874B Est
Benzinga
2026.10.27
Scott Galloway Warns Tesla Is the ‘Patient’ and SpaceX Its ‘Organ Donor’ in Elon Musk’s $3.5 Trillion Merger Plan: 'Real Merger With a Fake Premise'
Benzinga
2026.10.27
CMS Energy Affirms FY2027 Adj EPS Guidance of $4.08-$4.17 vs $4.15 Est
Benzinga
2026.10.27
CMS Energy Affirms FY2026 Adj EPS Guidance of $3.83-$3.90 vs $3.87 Est
Benzinga
2026.10.27
Nova Minerals Receives Final Antimony Project Approvals From The State Of Alaska; Targeting Production In 2027
Benzinga
2026.10.27
Applied Industrial Techs Sees Q2 Sales $1.233B-$1.256B vs $1.255B Est
Benzinga
2026.10.27
General Motors To Transfer Its Common Stock Listing From The NYSE To The Nasdaq Global Select Market, Effective November 17
Benzinga
2026.10.27
ChargePoint Unveils Channel Partner Program To Help European Resellers Capture Growing Demand For EV Charging Infrastructure
Benzinga
2026.10.27
Why Is Whirlpool Stock Falling Tuesday?
Benzinga
2026.10.27
Needham Maintains Buy on Applied Optoelectronics, Lowers Price Target to $170
Benzinga
2026.10.27
CenterPoint Energy Q3 Adj. EPS $0.53 Beats $0.49 Estimate, Sales $2.191B Beat $2.173B Estimate
Benzinga
2026.10.27
Microsoft Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Benzinga
2026.10.27
TransUnion Raises Share Buyback Authorization By $1B To $2B Total
Benzinga
2026.10.27
TransUnion Raises FY2026 Adj EPS Guidance from $4.75-$4.83 to $4.81-$4.88 vs $4.78 Est; Raises FY2026 Sales Guidance from $5.127B-$5.162B to $5.131B-$5.162B vs $5.161B Est
Benzinga
2026.10.27
TransUnion Sees Q4 Adj EPS $1.15-$1.22 vs $1.20 Est; Sees Sales $1.264B-$1.294B vs $1.296B Est
Benzinga
1
...
495
496
497
498
499
500
...
712
>